Thomas H. Lee Partners to Acquire Intermedix

June 24, 2011
Fort Lauderdale, Fla.-based Intermedix Corporation, a revenue cycle management and software solutions provider to the emergency healthcare industry,

Fort Lauderdale, Fla.-based Intermedix Corporation, a revenue cycle management and software solutions provider to the emergency healthcare industry, announced today that Thomas H. Lee Partners, L.P. (THL), based in Boston, Mass., has signed a definitive merger agreement to acquire the Company from Parthenon Capital Partners, a mid-market private equity firm based in Boston and San Francisco.

The transaction, which has received early clearance under the Hart-Scott-Rodino Act, is expected to close next month. Financial terms of the transaction were not disclosed.

Goldman, Sachs & Co. acted as financial advisor and Kirkland & Ellis LLP acted as legal advisor to Intermedix. Citi and Wells Fargo Securities acted as financial advisors and Weil, Gotshal & Manges LLP acted as legal advisor to THL in connection with the transaction. Citi, Wells Fargo and TCW/Crescent Mezzanine Management V, LLC provided financing commitments to THL to support the transaction.


Sponsored Recommendations

How Digital Co-Pilots for patients help navigate care journeys to lower costs, increase profits, and improve patient outcomes

Discover how digital care journey platforms act as 'co-pilots' for patients, improving outcomes and reducing costs, while boosting profitability and patient satisfaction in this...

5 Strategies to Enhance Population Health with the ACG System

Explore five key ACG System features designed to amplify your population health program. Learn how to apply insights for targeted, effective care, improve overall health outcomes...

A 4-step plan for denial prevention

Denial prevention is a top priority in today’s revenue cycle. It’s also one area where most organizations fall behind. The good news? The technology and tactics to prevent denials...

Healthcare Industry Predictions 2024 and Beyond

The next five years are all about mastering generative AI — is the healthcare industry ready?